Supplemental Data
Figure S1, related to figure 1 and main text: Tetracycline-susceptible E. coli grown in pre-conditioned, tetracycline-containing media. Y-axes give the absorbance at 600nm, corrected for the background value of a media-only control. Each panel depicts growth of the susceptible strain in media conditioned by E. coli expressing (i) the indicated inactivation gene (blue), (ii) a resistant transporter (green), or (iii) unconditioned media (black). The tet(X) ORF was used as a positive control for tetracycline inactivation. Values are the average of three trials; error bars depict st. dev. + equals 445 in positive ion mode) and associated reaction products (see legend). The data is generated from the reactions using tetracycline depicted in figures S2-S3. Putative structures for the indicated products are depicted in figures 6 and S6. (L) Representative spectra for ions discussed in this manuscript. The asterisk (*) denotes a sample where multiple ions (m/z 445 and 461) were not sufficiently resolved by retention time; 78% of the represented sample (based on raw ion counts) can be attributed to the ion with mass 461. Observed retention times are consistent with the expected polarity of the structures depicted in figure S6 . The ion with an m/z value of 387 does not absorb beyond 280nm, consistent with the loss of conjugation in figure S6 . 
[anhydrotetracycline]
T e t ( 4 9 ) T e t ( 5 2 ) T e t ( 5 5 ) T e t ( 5 0 ) T e t ( 5 4 ) T e t ( 5 6 ) T e t ( 5 1 ) T e t ( X ) Figure S5 , related to figures 4 and 5: Flavoenzymes oxidize tetracycline in multiple fashions. (A) Representative MS1 spectra from direct-injection, high resolution tandem MS. All spectra are available in supplementary dataset 1. Peaks marked with an 'X' indicate background ions associated with the reaction, as shown in (E) and (G-J). The product labeled in red was used to generate the fragmentation profile pictured in ( shows the elimination of oxytetracycline over the course of three hours, in a reaction containing the indicated purified enzyme (or control), oxytetracycline, and an NADPH regeneration system. Absorbance scans were taken at one minute intervals. The rainbow pattern depicts a spectral change over time; absorbance at 360nm or 400nm always decreased with time. 
Supplemental Experimental Procedures

Sub-Cloning of Tetracycline Resistance Genes into pZE21
For each soil-derived, putative FAD-dependent oxidoreductase, the full-length ORF was subcloned from the purified PCR-product that resulted from amplifying the resistance-conferring metagenomic DNA fragments in original the tetracycline selections (Forsberg et al., 2014) . PCRs were performed in a total volume of 25µl using the following reagents: 1µl of template (amplified PCR product), 1µl of 10mM dNTPs (NEB, Ipswich, MA), 2.5µl of 10x ThermoPol buffer (NEB), 0.5µl of Taq polymerase (NEB, 5U/µl), and 1µl each of forward and reverse primer, at 10µM. All reactions were incubated at 94ºC for 10 minutes, subjected to 35 cycles of: (i) 94ºC for 45 seconds, (ii) reaction-specific annealing temperature for 45 seconds, and (iii) 72ºC for a reactionspecific extension time, and finally incubated at 72ºC for 10 minutes before being held at 4ºC. Target-specific accession numbers and reaction-specific primer sequences/cycling conditions are indicated in table S2.
The Legionella homolog was cloned from a genomic DNA preparation from L. longbeachae (ATCC 33462). Lawns of L. longbeachae grown on charcoal yeast extract agar plates were given generously by Dr.
Joseph Vogel (Washington University in St. Louis) and cells collected by scraping and combining growth from three agar plates. Cells were pelleted and genomic DNA extracted via bead-beating and phenol-chloroform extraction. Cell pellets were re-suspended in 500µl "Buffer A" (200mM NaCl, 200mM Tris, 20mM EDTA), and 210µl of 20% SDS and 500µl of phenol:chloroform:IAA (25:24:1, pH7.9) were added to the mixture. The solution was then added to 250µl of 0.1mm zirconium beads (BioSpec Products, Bartlesville, OK, cat#1107910) before cooling on ice for five minutes. Cells were lysed by bead-beating with the mini beadbeater 24 (BioSpec Products, cat#112011) at maximum intensity for two minutes, cooled on ice for two minutes, and beat again for two minutes. Lysed cells were spun at 6800 rcf at 4ºC for three minutes and the aqueous phase transferred to a pre-spun phase-lock gel tube (5Prime, Gaithersburg, MD, cat#2302820). One volume of phenol:chloroform:IAA (25:24:1), pH7.9 was added to the tube and mixed by inversion. Tubes were then spun at 20800 rcf at room temperature for five minutes. The aqueous phase was transferred to a new microcentrifuge tube and one volume of -20ºC isopropanol and 1/10 th volume 3M NaOAc (Ambion, Austin, TX, cat#AM9740, pH 5.5) added. After overnight storage at -20ºC, the tube was spun in a pre-chilled (4ºC) tabletop centrifuge before a wash with 500µl of room-temperature ethanol was performed. After washing, the tube was spun down a final time, residual ethanol removed by evaporation, and the DNA pellet re-suspended in 50µl of warm, nuclease-free H2O. An aliquot of this genomic DNA preparation (2µl, 340ng) was used for PCRamplification of the target homolog with the conditions outlined in the preceding paragraph, and according to the reaction-specific parameters outlined in table S2.
Both control genotypes (tet(X) and the tetracycline-resistant transporter) were amplified via PCR using template extracted from functional selections with fecal metagenomic libraries. Templates were extracted exactly as outlined previously for selections with soil libraries (Forsberg et al., 2014) . The transporter was amplified from accession #KF630260, as described previously and with reaction-specific and gene-specific information provided in To facilitate cloning, Taq-amplified PCR products were blunted using the END-IT enzyme mix (Epicentre, Madison, WI cat#ER0720) and ligated to the expression vector using the Fast-Link DNA ligation kit (Epicentre, cat#LK11025). PCRs performed with PFX (a blunt-end polymerase) were phosphorylated (rather than blunted) prior to ligation using T4 PNK (Epicentre, cat#P0505H) per manufacturer's recommendations.
All sub-cloned genes were verified to confer tetracycline resistance when expressed in E. coli MegaX at a minimum of 16µg/ml and subjected to Sanger sequencing to confirm appropriate sequence and orientation. In some instances, small discrepancies between the confirmatory Sanger sequence and the original Illuminagenerated, assembled sequence were observed (Forsberg et al., 2014) , none of which impacted resistanceconferring activity when expressed in E. coli. In two constructs (tet(47) and tet (48)), multiple in-frame start codons were present in the assembled metagenomic contigs which resulted in several potential open reading frames for which a priori predictions of optimality were not obvious. In both cases, the longest potential open reading frame was cloned from its metagenomic source (1248bp and 1200bp for tet(47) and tet(48), respectively); accession numbers corresponding to the exact sequences used in this study are reported in table S2. Accession numbers for the original metagenomic contigs are reported in table S1.
Determination of Tetracycline Minimum Inhibitory Concentrations
Determination of all minimum inhibitory concentrations was performed in liquid media using MuellerHinton broth (2g Beef Infusion Solids, 1.5g Starch, 17.5g Casein hydrolysate, pH 7.4, in a final volume of 1L)
supplemented with 50μg/ml kanamycin (the resistance marker on the pZE21 expression vector) and tetracycline at the reported concentrations. All minimum inhibitory concentrations were performed in a final volume of 200μl, with a 2.5% initial cellular inoculum. Growth of E. coli transformants was profiled via absorbance measurements at 600nm (OD600) using the Synergy H1 microplate reader (Biotek Instruments, Inc, Winooski, VT) for a minimum of 48 hours at 37ºC. Cultures were protected from light. MIC determinations were performed using E. coli strains transformed with all soil-derived tetracycline inactivation genes and the homolog from L. longbeachae.
Tetracycline Media-Darkening Growth Assays
E. coli transformants expressing either the tetracycline-resistant transporter (control) or a putative tetracycline-inactivating protein were grown in 8ml of Luria-Bertani (LB) broth (5g Yeast Extract, 5g NaCl, 10g of Tryptone in 1L H2O) at 37ºC for 4 days, protected from light, and shaking at 225 rpm. Cultures were inoculated with 10µl of starter culture grown to an optical density that ranged from 0.35 to 0.54 (excepting the transformant expressing the ORF from L. longbeachae, for which 20µl of starter culture with an optical density of 0.17 was used). To the cultures indicated in figure 2, tetracycline was added at a concentration of 100µg/ml, excepting the tet(55) construct, as this drug concentration inhibited the growth of this transformant. For this culture only, 32µg/ml tetracycline was used. After 96 hours, images were taken using a standard digital camera.
Detecting Tetracycline Inactivation with Conditioned-Media Growth Assays
To test for the ability of the E. coli transformants expressing the various tetracycline resistance proteins to inactivate the antibiotic, we grew each transformant in tetracycline-containing media, filtered out cells, and compared the cytotoxicity of the spent supernatant to either (i) unconditioned media, or (ii) media conditioned with an E. coli transformant encoding a tetracycline-resistant transport protein. To condition media, an inoculum of log phase E. coli transformants was introduced to 10ml of Mueller-Hinton broth containing 50μg/ml kanamycin (the resistance marker on the pZE21 expression vector) and 8μg/ml tetracycline. The inoculated cells were determined to be in log phase via absorbance measurements at OD600 using the Synergy H1 microplate reader (Biotek Instruments, Inc) every 15 minutes and were introduced into fresh media at the densities and volumes outlined in table S3. Cultures were grown until reaching an OD600 measurement of ~0.5-1.0, at which point cells were pelleted and the supernatant passed through a 0.2µM filter. Due to variable growth rates, cultures used to condition media were grown for different periods of time to reach the appropriate cellular density: one batch was grown for 24 hours while a second was allowed to progress 42 hours. As detailed in table S3, the appropriate negative controls (unconditioned media and transporter-conditioned media)
were repeated for both intervals. To verify that the initial concentration of tetracycline (8μg/ml) entirely prevented the growth of our tetracycline-susceptible E. coli strain (MegaX + an empty pZE21 vector), the control strain was inoculated into Mueller-Hinton broth containing 50μg/ml kanamycin and 8μg/ml tetracycline, per table S3. No growth was observed (table S3) , confirming the potency of the tetracycline antibiotic.
After conditioning and filtration, supernatants were used as growth media for the tetracyclinesusceptible E. coli strain. In all cases, growth assays were performed in a final volume of 225μl supernatant inoculated with 5μl of tetracycline-susceptible E. coli at an OD600 value of 0.6. Growth was profiled via absorbance measurements at 600nm using the Synergy H1 microplate reader (Biotek Instruments, Inc) every 15 minutes for a minimum of 60 hours at 37ºC. Cultures were protected from light. Absorbance values were corrected for the background absorbance of the filtered supernatant by subtracting measurements of uninoculated controls from those receiving inoculum.
Quantifying Tetracycline Levels via Liquid Chromatography-Tandem Mass Spectrometry
To confirm E. coli transformants expressing the various tetracycline resistance proteins inactivate the antibiotic, levels of the drug were quantified in growth media by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Strains were grown in 10ml of M9 minimal media (1X M9 minimal salts [Sigma,
St. Louis, MO, cat #M6030], 2mM MgSO4, 100μM CaCl2) supplemented with 9g/L glucose, 100mg/L thiamine (Sigma #T4625), 100mg/L leucine (Sigma #L8912), 8μg/ml tetracycline (Sigma #268054), and 15.1 mg/L PIPES (piperazine-N,N′-bis(2)-ethanesulfonic acid; Sigma #P6757, used as an internal control for quantification via mass spectrometry). Cultures were inoculated with transformants previously grown for 13 hours at 37ºC and normalized to the optical density of the transformant, according to table S4. Strains were allowed to grow for 48 hours, shaking continuously at 225rpm and protected from light, to OD600 values given in table S4.
Subsequently, cells were pelleted and supernatants passed through a 0.2µM filter before tetracycline levels were quantified via LC-MS/MS by Dr. Sophie Alvarez at the Proteomics and Mass Spectrometry Facility at the Donald Danforth Plant Science Center (St. Louis, MO USA).
To quantify absolute tetracycline levels, LC-MS/MS was performed using filtered supernatants diluted three-fold and transferred to HPLC vials. The LC-MS/MS system used is composed of a Shimadzu (Kyoto, Japan) LC system with two Shimadzu solvent delivery pumps (model LC10AD), a Shimadzu integrated controller (SCL10Avp), a Valco (Houston, TX) two-position diverter valve, and a LEAP CTC PAL autosampler with a 50 µl sample loop. This LC system is interfaced with an AB Sciex (Framingham, MA) 4000
QTRAP mass spectrometer equipped with a TurboIonSpray (TIS) electrospray ion source. Source parameters were set as follows: curtain gas, 20 arbitrary units (a.u.); source gas 1, 50 a.u.; source gas 2, 50 a.u.; collision activated dissociation, high; interface heater, on; temperature, 500 ºC; ion spray voltage, +5500. Both quadruples (Q1 and Q3) were set to unit resolution. Analyst software (version 1.4.2) was used to control sample acquisition and data analysis. The 4000 QTRAP mass spectrometer was tuned and calibrated according to the manufacturer's recommendations. Tetracycline and the internal standard used (PIPES) were detected using 3 MRM transitions previously optimized using each standard (tetracycline, Sigma #268054; PIPES, Sigma #P6757) as detailed in table S5.
For LC separation, a ZORBAX Eclipse XDB-C18 column (4.6 mm x 150 mm, Agilent, Santa Clara, CA) was used flowing at 0.5 ml/min. The gradient was from 95% solvent A (0.1% [v/v] formic acid in Milli-Q water), held for 2 min, to 80% solvent B (100% Methanol) in 8 min. The LC was then ramped to 95% B and held for 2.5 min, then ramped back to initial conditions (95% solvent A) in 1 min and re-equilibrated for an additional 2 min. For quantification, a series of standard samples containing different concentrations of tetracycline and a constant concentration of PIPES was prepared. The peak area in samples was first normalized in the same manner used for optimization of the standards and then quantified according to the standard curve.
The linear range of the standard curve for tetracycline quantification was between 0.008 and 10 µM, with an r 2 value of 0.999.
Sub-Cloning of Tetracycline Resistance Genes into pET28b(+)
All genes encoding putative tetracycline-inactivating enzymes were cloned into the pET28b(+) vector (Novagen, Darmstadt, Germany) digested using BamHI and NdeI restriction enzymes. Digestion of the pET28b(+) vector was performed in a total volume of 50µl using the following reagents mixed well and incubated at 37ºC overnight: (i) 2.5µg of purified vector DNA, isolated via miniprep with a Qiagen purification kit (Venlo, Netherlands, cat#27104) per manufacturer's recommendations, (ii) 5µl NEB cutsmart buffer, (iii) 0.67µl BamHI-HF (100U/µl, NEB), and (iv) 3µl NdeI (20U/µl, NEB). Subsequently, digested vector was dephosphorylated using 1/10 th volume calf intestinal phosphatase (CIP, 10U/µl, NEB) with 1/10 th volume NEB buffer #3 followed by incubation at 37 o C for three hours. BamHI and NdeI cut sites were added to each cloned putative tetracycline-inactivating gene using ~1-2ng of template (subcloned genes in pZE21) and the PFX DNA polymerase, per suggested protocols (http://tools.invitrogen.com/content/sfs/manuals/platinumpfx_pps.pdf). All reactions were incubated at 94ºC for 10 minutes, subjected to 35 cycles of: (i) 94ºC for 45 seconds, (ii) reactionspecific annealing temperature for 45 seconds, and (iii) 72ºC for a reaction-specific extension time, and finally incubated at 72ºC for 10 minutes before being held at 4ºC. Reaction-specific primer sequences/cycling conditions are indicated in table S6.
Purified PCR product was digested in a 50µl reaction incubated at 37 o C overnight and containing (i) 30µl of pure amplicon (2 -4.8µg DNA), ii) 5µl NEB cutsmart buffer, (iii) 0.67µl BamHI-HF (100U/µl, NEB), (iv) 3ul
NdeI (20U/µl, NEB), and (v) 1µl of DpnI (20U/µl, NEB, to linearize residual pZE21 vector containing subcloned tetracycline resistant genes). To facilitate cloning, each digested amplicon was ligated to digested pET28b(+) using the Fast-Link DNA ligation kit (Epicentre, cat#LK11025) per manufacturer's recommendations. All cloned genes were subjected to Sanger sequencing to confirm appropriate sequence and orientation.
Enzyme Purification
After ligation into pET28b(+), all putative tetracycline-inactivating genotypes were purified by miniprep and transformed into BL21-Star(DE3) E. coli cells (Life Technologies, Carlsbad, CA) via heat-shock. Enzymes were purified using similar protocols but in two separate groups of six; each group was purified on a separate day. Group #1 consisted of genotypes Tet (47) The following buffers were used in purification: Lysis buffer (50mM K2HPO4, 500mM NaCl, 5mM
Beta-Mercaptoethanol, 20mM imidazole, 10% glycerol), Elution buffer (50mM K2HPO4, 500mM NaCl, 5mM
Beta-Mercaptoethanol, 300mM imidazole, 10% glycerol), and Dialysis buffer (50mM K2HPO4, 150mM NaCl, 1mM DTT, 5% Glycerol). Samples were kept in a cold room at 4 o C or on ice throughout the purification process. After overnight induction with IPTG, each sample was pelleted by centrifugation at 10,000g for 10 minutes at 4 o C, supernatants discarded, and cells resuspended in 40ml of lysis buffer containing SIGMAFAST protease inhibitor (Sigma cat#S8820) at a concentration of one tablet in 100ml buffer. Resuspended cells were subsequently flash-frozen in liquid nitrogen and thawed in a room-temperature water bath. Cells were then lysed using an EmulsiFlex-C5 homogenizer (Avestin, Ottawa, Canada) at a minimum psi of 15,000, lysates collected, and clarified at 50,000 rpm for 35 minutes at 4 o C (samples in group #2 were clarified at 39,000 rpm).
From each sample, approximately 1ml of both lysate and clarified supernatant was stored for use in SDS protein gels.
Proteins were purified from supernatant by elution through Ni-NTA agarose beads (Invitrogen cat#R901), using 8ml of beads for samples in group #1 and 15ml for group #2 samples. After beads were washed twice with 50ml diH2O, clarified supernatant was mixed with the beads while gently rocking at 4 o C for 30 to 60 minutes to facilitate binding of the His6-tagged enzymes to the Ni-NTA beads. Bound beads were allowed to settle and the supernatant permitted to flow through purification columns and the drippings collected.
Beads were subsequently washed with 40ml of lysis buffer, with wash also collected by drip. Proteins were then eluted from Ni-NTA beads by flowing elution buffer over beads three separate times, each elution was collected separately, and mixed before dialysis. Samples in group #1 were eluted with three volumes of 20ml elution buffer while group #2 samples used elution volumes of 10ml. All group #1 samples were dialyzed using 10 kDa molecular weight cut-off SnakeSkin Pleated Dialysis tubing from Thermo Scientific (Waltham, MA) in 2L dialysis buffer overnight before transfer into a fresh 4L of dialysis buffer the following day, and allowed to dialyze for additional 5 hours, reaching a final 1:80 dilution. Each sample from group #2 was dialyzed in 1L of dialysis buffer overnight using the same tubing; for a final 1:34 dilution. For each sample, aliquots of supernatant flow-through, washes, and each elution were maintained for use in SDS protein gels.
Running SDS Protein Gels
For each sample, an SDS protein gel was run using uninduced cells, induced cells, lysate, clarified supernatant, flowthrough, wash, elution #1, elution #2, and elution #3. of sample was loaded on SDS gels whereas 15µl was used for flowthrough, washes, and all elutions. As a size marker, 12µl of BioRad (Hercules, CA) Precision Plus Dual Xtra Standard (cat#161-0377) was included. The loaded SDS gels (BioRad Any kD Mini-PROTEAN TGX Gel; cat#456-9033) ran for 10 minutes at 150 volts and then 35 minutes at 185 volts. Gels were subsequently stained with coomassie blue dye and then destained by gentle rocking overnight using a 10/10/80 ratio of acetic acid to methanol to water. Gels were imaged the subsequent day; the expected size of all tetracycline-inactivating enzymes is approximately 44KDa. For samples Tet(47) and Tet(53) , no band of the desired size was visible in any elution, indicating purification was unsuccessful. These samples were not carried through to further in vitro experimentation.
Concentrating, Quantifying, and Storing Enzymes
To concentrate samples, dialyzed eluate was loaded into a 10kDa centrifugal filtration unit (Millipore, Darmstadt, Germany, cat#ACK5010PG), removing proteins smaller than 10KDa. Before sample was loaded, concentration columns were conditioned with 15ml of dialysis buffer and centrifuged at 4,500 rpm for 15 minutes at 4 o C. Samples were then concentrated in 15ml aliquots and precipitate avoided by periodic gentle pipetting. All samples were concentrated to volumes below 1.7ml and concentration quantified using A280 measurements taken with a NanoDrop Spectrophotometer (Thermo Scientific). For each enzyme, extinction coefficients were determined using ExPASy's ProtParam tool (http://web.expasy.org/protparam) assuming reduced cysteines; all parameters, concentrations, and yields are reported in table S7. Notably, solutions of purified protein showed a yellow hue in a concentration-dependent fashion, indicating likely flavin content (Yang et al., 2004) .
Preparing In vitro Enzymatic Reactions
All reactions were performed using 100mM TAPS buffer (Sigma #T5130), pH 8.5, unless otherwise noted. Inactivation reactions contained 1.4mM antibiotic (either tetracycline or oxytetracycline), 350µg enzyme, and an NADPH regenerating system in a total volume of 564µl. For reactions using anhydrotetracycline, 1mM substrate was used with 200ug enzyme in a 475ul reaction. The NADPH regenerating system consisted of the following components (final concentrations): glucose-6-phosphate (40mM, Sigma #G7879), NADP + (4mM, Sigma #N5755), MgCl2 (1mM, Sigma #M9272), and glucose-6-phosphate dehydrogenase (4U/ml, Sigma #G2921). Before addition to the reaction, the regenerating system was prepared as a 4X stock as follows. The glucose-6-phosphate and NADP + were dissolved in TAPS and the mixture pH'ed to 8.4 before the addition of MgCl2 and glucose-6-phosphate dehydrogenase. The solution was then incubated at 37ºC for 30 minutes to generate NADPH before the regeneration solution was added to each reaction. The reaction was started by the addition of a putative tetracycline-inactivating enzyme. Before enzyme addition, the pH of each reaction was measured and verified to be between 8.1 and 8.3. Enzymes were thawed on ice with FAD added to a final concentration of 5µM. FAD was also added to 'no-enzyme' controls, matched to the highest concentration in any other experiment. The same reactions were used for UV-visible spectroscopy (following dilution), reverse phase HPLC, and (where applicable) LC-MS and high-resolution tandem MS.
UV-visible Spectroscopy
After enzyme addition, reactions were immediately mixed and 25µl added to 975µl TAPS (40-fold dilution)
such that absorbance readings would fall within the dynamic range of the spectrometer used (a Cary 60 UV/Vis system, Agilent). For reactions using anhydrotetracycline, a 50-fold dilution factor was used. Absorbance then was measured from 280nm to 450nm or 550nm light, at 1-5nm intervals, for up to 3.5 hours. Time course spectra can be seen in figures 3, 6, and S7.
Sampling Reactions
From each reaction, samples were taken at indicated timepoints by transferring a 50µl volume into a 200µl quencher solution comprised of equal parts acetonitrile (Sigma #34851) and 0.25M HCl. Reactions were quenched under acidic conditions because prior work with Tet(X) demonstrated that enzymatic degradation products of tetracyclines are unstable at neutral pH, but stable at low pH (Moore et al., 2005; Yang et al., 2004) .
In many cases, soil-derived enzymes showed similar initial products as Tet(X) by reverse phase HPLC.
Reactions that appeared to progress slowly accumulated less degradation product, consistent its lower stability at neutral pH. Slower reactions expose products to unfavorable pH levels for longer periods of time and would therefore be expected to result in diminished levels of any compound unstable at the reaction's pH. After an aliquot of reaction was quenched, the sample was centrifuged at 10,000 rpm for 10 minutes at 4 o C and 200µl transferred to a suitable vial for reverse phase HPLC.
High Performance Liquid Chromatography to Separate Tetracycline Degradation Products
Products generated from enzymatic inactivation of both tetracycline and oxytetracycline were separated by reverse phase HPLC using a Phenomenex (Torrance, CA) Luna C18 column (5µm, 100 Å, 4.6 x 250mm, part #00G-4252-E0). The column was first equilibrated using H2O containing 0.1% trifluoroacetic acid (solvent
